The effects of pneumolysin on the proinflammatory activity of human neutrophils, as well as on cation fluxes in these cells, have been investigated. Superoxide production, release of elastase, CR3 expression, phospholipase A 2 activity, and alterations in membrane potential were measured by use of lucigenin-enhanced chemiluminescence and colorimetric, flow cytometric, radiometric, and spectrofluorimetric procedures, respectively; and cation fluxes were measured by use of 45 Ca 2+ and 86 Rb + and by fura-2 spectrofluorometry. Pneumolysin at concentrations 11 .67 ng/mL caused influx of Ca 2+ and increased phospholipase A 2 activity and CR3 expression, which were associated with enhanced superoxide production and release of elastase after activation of the cells with the chemotactic tripeptide FMLP. At the same concentrations, pneumolysin caused efflux of K + and membrane depolarization. The effects of pneumolysin on cation fluxes were not attributable to inhibition of Ca Pneumolysin, a membrane-damaging, pore-forming toxin produced by Streptococcus pneumoniae, is considered to be intimately involved in the pathogenesis of infections caused by this microbial pathogen [1] . Although the involvement of the toxin in the pathogenesis of pneumococcal meningitis [2] and otitis media [3] is less compelling, evidence derived from animal models of experimental infection and inflammation clearly supports a primary role for pneumolysin in the etiology of inflammatory events and tissue damage in pneumococcal pneumonia [4] [5] [6] [7] , septicemia [5] , and ocular infections [8] . Interestingly, pneumolysin-mediated ocular damage in rabbits is attenuated by previous induction of leukopenia [9] . The proinflammatory potential of pneumolysin is supported by in vitro studies, in which treatment of human phagocytes with this microbial toxin resulted in increased release of granule enzymes [10] and proinflammatory cytokines [11] . Although some of the proinflammatory effects of pneumolysin may be due to cytolysis of various host cell types, including ciliated respiratory epithelium [12] , endothelial cells [13] , and type II alveolar epithelial cells [14] , as well as to activation of phospholipase A 2 (PLA 2 ) in endothelial cells [15] , relatively little is known about the pro-inflammatory actions of sublytic, pathologically relevant concentrations of the toxin.
In the current study, we investigated the effects of pneumolysin on several proinflammatory activities of human neutrophils and related changes in these in response to alterations in the permeability of the outer membrane of these cells to Ca 2ϩ and K ϩ .
Materials and Methods
Pneumolysin. Recombinant pneumolysin was expressed in Escherichia coli and was purified from cell extracts, as described elsewhere [16] . Protein homogeneity was confirmed by SDS-PAGE. An attenuated form of the toxin was generated by oligonucleotidemediated, site-directed mutagenesis [17] . This mutant contains a tryptophan to phenylalanine substitution at position 433 in the protein. The stock concentrations of the biologically active and mutant toxins contained 0.21 and 0.30 mg/mL of protein, respectively, which corresponded to and hemolytic U/ 6 2 1.3 ϫ 10 1.4 ϫ 10 mL. These pneumolysin preparations were essentially free of contaminating bacterial endotoxin (!2 pg/mL) and were diluted in the same endotoxin-free Hanks' balanced salt solution (HBSS [pH 7.4, 1.25 mM CaCl 2 ]; Highveld Biological), which was added to the pneumolysin-free control systems described below.
Chemicals and reagents. Unless indicated otherwise, chemicals and reagents were obtained from Sigma, and radiochemicals were purchased from DuPont NEN Research Products.
Neutrophils. Purified neutrophils were prepared from heparinized (5 U/mL of preservative-free heparin) venous blood from healthy adult volunteers and were separated from mononuclear leukocytes by centrifugation on Histopaque-1077 (Sigma Diagnostics) cushions at 400 g for 25 min at room temperature. The resultant pellet was suspended in PBS (0.15 M, pH 7.4) and was sedimented with 3% gelatin to remove most of the erythrocytes. After centrifugation, erythrocytes were removed by selective lysis with 0.84% ammonium chloride at 4ЊC for 10 min. The neutrophils, which were routinely of high purity (190%) and viability (195%), were resuspended to cells/mL in PBS and were held on ice 7 1 ϫ 10 until used.
Cytotoxic activity of pneumolysin. Cytotoxic activity of pneumolysin was determined by measurement of intracellular ATP levels, using a sensitive luciferin-luciferase chemiluminescence procedure [18] , and by spectrophotometric measurement of lactate dehydrogenase (LDH) in cell-free supernatants of neutrophils ( cells/mL) that had been incubated with active pneumolysin 6 1 ϫ 10 (0.0167-41.75 ng/mL) for 10 min at 37ЊC in Ca 2ϩ -free HBSS or Ca 2ϩ -replete HBSS, without and with 5 mM EGTA. Superoxide production. Superoxide production was measured by use of a lucigenin (bis-N-methylacridinium nitrate) chemiluminescence procedure [19] . Neutrophils ( cells) were preincu- 6 1 ϫ 10 bated for 5 min at 37ЊC in 800 mL of indicator-free HBSS containing 0.2 mM lucigenin, followed by addition of native (0.0167-41.75 ng/mL final) or mutant (1.62-8077 ng/mL final) pneumolysin. In some experiments, the neutrophils were suspended in HBSS that was nominally free of Ca 2ϩ (∼2 mM, according to the manufacturer) or in Ca 2ϩ -replete HBSS to which the extracellular calcium-chelating agent EGTA (5 mM final) was added 1 min before pneumolysin. The vials were then reincubated for 10 min at 37ЊC, after which basal chemiluminescence was recorded with a Lumac Biocounter (Lumac Systems), followed by activation of the neutrophils with the synthetic chemotactic tripeptide FMLP (1 mM final) and measurement of lucigenin chemiluminescence. The final volume in each vial was 1 mL, and the results are expressed in relative light units (rlu). The peak values for FMLP-stimulated systems were reached 40-50 s after addition of the stimulant and have been corrected for background (i.e., subtraction of the value for the corresponding unstimulated systems).
Elastase release. Neutrophil degranulation was measured according to the extent of release of the primary granule enzyme elastase. Neutrophils were incubated at a concentration of 6 2 ϫ 10 cells/mL in HBSS, with and without active pneumolysin (0.0167-41.75 ng/mL), for 10 min at 37ЊC. FMLP (1 mM), in combination with a submaximal concentration of cytochalasin B (CB; 1 mM final), was then added to the cells, which were incubated for 15 min at 37ЊC. The tubes then were transferred to an ice bath, followed by centrifugation at 400 g for 5 min to pellet the cells. The neutrophil-free supernatants were then decanted and were assayed for elastase by a micromodification of a standard colorimetric procedure [20] . In brief, 125 mL of supernatant was added to the 2.5 ϫ 10 preincubated for 10 min at 37ЊC, followed by the addition of active pneumolysin (0.0167-41.75 ng/mL). The final volume was 2 mL. After 3 min of incubation at 37ЊC, the reactions were terminated, and 3 H-arachidonate was extracted by the addition of 5 mL of chloroform:methanol (2:1 vol/vol) and thorough mixing. The lower organic phase was removed and was evaporated to dryness under a nitrogen stream. The lipids were reconstituted in 40 mL of chloroform-methanol and were spotted onto thin-layer chromatography plates precoated with silica gel (Merck), together with 2 mM unlabeled arachidonate standard, to facilitate detection. The plates were developed in chloroform:acetone (96:4 vol/vol) and were then exposed to iodine vapors. The arachidonate spots were localized, excised, and assayed for radioactivity.
Spectrofluorimetric measurement of cytosolic Ca 2ϩ . Fura-2/AM (Calbiochem) was used as the fluorescent Ca 2ϩ -sensitive indicator for these experiments [22] . Neutrophils ( cells/mL) were pre-7 1 ϫ 10 loaded with fura-2 (2 mM) for 30 min at 37ЊC in PBS, washed twice, and resuspended in indicator-free HBSS. The fura-2-loaded cells ( cells/mL) then were preincubated for 10 min at 37ЊC, 6 2 ϫ 10 after which they were transferred to disposable reaction cuvettes that were maintained at 37ЊC in a Hitachi 650 10S fluorescence spectrophotometer, with excitation and emission wavelengths set at 340 and 500 nm, respectively. After a stable baseline was obtained, active or mutant pneumolysin (0.0167-41.75 ng/mL and 1.62-8077 ng/mL, respectively) or an equal volume of HBSS (control system) was added to the cells, and fluorescence intensity was monitored over a 5-min period. The final volume in each cuvette was 3 mL, containing a total of neutrophils. The effects of 6 6 ϫ 10 treatment of the cells with 10 mM EGTA and with U-73122 (10 mM), a phospholipase C inhibitor [23] , on pneumolysin-mediated alterations in cytosolic Ca 2ϩ neutrophils also were investigated. EGTA was added to the cells 60 s before pneumolysin, and U-73122 was present with the cells throughout the 10-min preincubation period.
Membrane potential. The potential sensitive fluorescent dye 3,3-dipentyloxacarbocyanine (di-0-C5 [3] ) was used to measure changes in membrane potential in neutrophils. The cells ( 6 1 ϫ 10 cells/mL) were preincubated for 10 min at 37ЊC in HBSS containing 80 nM (final) di-0-C5(3), after which they were transferred to disposable reaction cuvettes that were maintained at 37ЊC in a Hitachi 650 10S fluorescence spectrophotometer, with excitation and emission wavelengths set at 460 and 510 nm, respectively. The neutrophils were then treated with active pneumolysin (0.0167-41.75 ng/ mL) or an equivalent volume of HBSS (control system), and the subsequent alterations in fluorescence intensity were monitored over 5-10 min.
Ca 2ϩ -adenosine triphosphatase (ATPase) activity. Plasma membrane Ca 2ϩ -ATPase activity was measured according to the 45 Ca 2ϩ over 30 min at 37ЊC. Reactions were stopped by the addition of 10 mL of ice-cold Ca 2ϩ -replete HBSS to the tubes, which were transferred immediately to an ice bath. The cells were then pelleted by centrifugation at 400 g for 5 min, followed by washing with 15 mL of ice-cold Ca 2ϩ -replete HBSS. The pellets were finally dissolved in 0.5 mL of 0.5% Triton X-100/0.1 M NaOH, and the radioactivity was assessed in a liquid scintillation spectrometer (Packard). The results are presented as the amount of cell-associated radiolabeled cation (pmol 45 Ca 2ϩ /10 7 cells). A comparison of this procedure with silicone oil-based methods for the separation of labeled neutrophils from unbound isotope has been described elsewhere [24] .
Assay of transmembrane fluxes of K ϩ .
86
Rb ϩ was used as a tracer for measuring K ϩ uptake and efflux [25] . For uptake studies, neutrophils ( cells/mL) were suspended in isotonic Tris buf- 6 1 ϫ 10 fer (122 mM NaCl, 4 mM KCl, 1 mM MgSO 4 , 1 mM KH 2 PO 4 , 20 mM Tris, and 5 mM glucose [pH 7.4]) and were preincubated for 30 min at 37ЊC, followed by serial addition of 2 mCi 86 Rb (specific activity, 3.56 mCi/mg) and pneumolysin (8.35 and 41.75 ng/mL to each tube; final volume, 2 mL). After 30 min of incubation at 37ЊC, the reactions were terminated by the addition of ice-cold Tris buffer. The cells were then washed twice, and the pellets were dissolved in 0.5 mL of 0.5% Triton X-100/0.1 M NaOH. The radioactivity was assayed with a liquid scintillation spectrometer (Packard). Na ϩ , K ϩ -ATPase activity was taken as the difference in 86 Rb ϩ uptake in the presence and absence of 50 mM ouabain. The contribution of PLA 2 to alterations in the uptake of 86 
Rb
ϩ by pneumolysin-treated neutrophils was investigated by the inclusion of a-tocopherol vitamin E (25 mg/mL final; Hoffman-La Roche), which neutralizes lysophosphatidylcholine [26] -replete HBSS, a decrease in intracellular ATP in the setting of an increase in the release of LDH was observed at the highest concentration (41.75 ng/mL) of the toxin, but not at lower concentrations. However, the cytotoxic potential of pneumolysin was enhanced when the cells were suspended in Ca 2ϩ -free HBSS with reduced ATP levels, and increased release of LDH was observed at concentrations of 8.37 and 1.67 ng/mL, respectively.
Superoxide production. The effects of active pneumolysin on superoxide production by FMLP-activated neutrophils are shown in figure 1 . Pneumolysin, at concentrations ofу1.67 ng/ mL, significantly sensitized neutrophils for increased production of superoxide after activation with FMLP, compared with the pneumolysin-free control system ( ). Maximal en-P ! .05 hancement was observed at у4.18 ng/mL of pneumolysin, with no significant differences in the magnitude of enhancement found at concentrations of 4.18-41.75 ng/mL. The kinetics of superoxide production by control-and pneumolysin (4.18 ng/ mL)-treated neutrophils are shown in figure 2. Pneumolysin enhancement of superoxide production by FMLP-activated neutrophils was associated with both an increase in and a prolongation of the peak response. Pneumolysin per se (in the absence of FMLP) did not affect superoxide production by neutrophils: the values for control cells and for those treated with 8.35 and 41.75 ng/mL of the toxin were , 1518 ‫ע‬ 145 , and rlu, respectively. 1515 ‫ע‬ 146 1030 ‫ע‬ 105 Pretreatment of neutrophils with the mutant toxin at concentrations р8077 ng/mL did not affect either spontaneous or FMLP-activated production of superoxide by neutrophils. The values for spontaneous production of superoxide by controland mutant pneumolysin (8077 ng/mL)-treated systems were and rlu, whereas the corresponding val-1674 ‫ע‬ 146 1522 ‫ע‬ 151 ues for FMLP-activated systems were and 4055 3592 ‫ע‬ 412 ‫ע‬ 537 rlu (background subtracted).
The possible involvement of Ca 2ϩ in pneumolysin-mediated enhancement of superoxide production was investigated by use of Ca 2ϩ -free HBSS. These results are shown in table 2. Relative to the responses observed in Ca 2ϩ -replete HBSS, suspension of neutrophils in Ca 2ϩ -free medium resulted in a modest reduction in superoxide production by control neutrophils, possibly through loss of Ca 2ϩ from stores [24] , whereas pneumolysin failed to stimulate, but rather inhibited, superoxide production. Similar results (not shown) were observed when the cells were suspended in Ca 2ϩ -replete HBSS containing 5 mM EGTA. Degranulation. The effects of active pneumolysin on the release of elastase by FMLP-CB-activated neutrophils are shown in figure 1 . At concentrations у4.18 ng/mL, the toxin significantly ( ) potentiated the release of elastase, with P ! .05 maximal enhancement observed at 41.75 ng/mL of pneumolysin. As in the case of superoxide production, however, the toxin per se, in the absence of FMLP-CB, did not affect the release of elastase from neutrophils. in neutrophils are shown in figure 5 , which depicts the fura-2 fluorescence responses (from 2 different experiments that used cells from different donors) of control cells and cells treated figure 6 (data from 3 experiments that used cells from different donors). EGTA prevented the increase in cytosolic Ca 2ϩ after exposure of the cells to pneumolysin, whereas fluorescence intensity was slightly increased in cells treated with U-73122. These experiments were repeated on 4 different occasions, and similar results were obtained. These observations indicate that the pneumolysin-mediated increase in the concentration of cytosolic Ca 2ϩ in neutrophils results from influx of extracellular Ca 2ϩ , as opposed to phospholipase C-mediated release of the cation from intracellular stores. The decline in fluorescence intensity observed in neutrophils treated with 41.75 ng/mL of pneumolysin in the presence of EGTA may be due to penetration of EGTA into the cells, resulting from toxin-mediated alterations in membrane integrity.
Treatment of neutrophils with U-73122 (10 mM) completely abolished the FMLP-mediated transient increase in neutrophil cytosolic Ca 2ϩ , confirming the efficacy of this agent as an inhibitor of phospholipase C-mediated mobilization of Ca 2ϩ from intracellular stores (data not shown).
Membrane potential. The effects of active pneumolysin at concentrations of 1.67, 8.35, and 41.75 ng/mL are shown in figure 7 . At concentrations of 8.35 and 41.75 ng/mL, pneumolysin caused depolarization of neutrophils (after a lag period of 1-2 min in the case of 8.35 ng/mL of the toxin), with no repolarization observed during the time course of the experiment. These experiments were repeated with cells from 7 different donors, with almost identical results.
Ca
2ϩ -ATPase activity. At concentrations of 8.37 and 41.75 ng/mL, pneumolysin did not inhibit, but rather slightly potentiated, the efflux of 45 Ca 2ϩ from neutrophils that had been preloaded with the cation. After incubation for 30 min at 37ЊC, the amounts of Ca 2ϩ released from pneumolysin-untreated control cells and from cells treated with 8.37 and 41.75 ng/mL of the toxin were , , and pmol Ca 2ϩ /10 7 cells, 49 ‫ע‬ 9 75 ‫ע‬ 2 ‫ע17‬ 4 respectively (results of 4 different experiments). Na ϩ , K ϩ -ATPase activity. Treatment of the cells with the toxin resulted in a striking dose-related decrease in the influx of the cation from the cells, in the setting of a dramatic increase in net efflux. With respect to influx, during which the cells were exposed to the toxin for 30 min at 37ЊC in medium containing 86 Rb ϩ , the amounts of cell-associated 86 Rb ϩ for control neutrophils and for cells treated with 8.37 and 41.75 ng/mL pneumolysin were , , and cpm 56,819 ‫ע‬ 1024 4525 ‫ע‬ 155 4657 ‫ע‬ 224 ( for comparison of both concentrations of the toxin P ! .05 with the control system). In the case of efflux experiments for which the cells were preloaded with 86 Rb ϩ and resuspended in medium that was free of the radiolabeled cation, followed by treatment of the cells with the toxin for 10 min at 37ЊC, the corresponding values were , , and 9144 ‫ע‬ 412 346 ‫ע‬ 81 261 ‫ע‬ cpm ( for comparison of both concentrations of the 14 P ! .05 toxin with the control system).
Two additional series of experiments were undertaken, to investigate the possible inhibition of Na ϩ , K ϩ -ATPase by pneumolysin, either indirectly, as a result of activation of PLA 2 , or by direct inhibition of the cation transporter, as a mechanism of toxin-mediated efflux of K ϩ . In the first of these, pretreatment of neutrophils with vitamin E only partially attenuated the pneumolysin-mediated reduction in the net influx of the cation. The absolute values for ouabain-inhibitable influx of 86 
Rb
ϩ into control neutrophils, without and with vitamin E, and into cells treated with 8.75 ng/mL of pneumolysin, in the 
Discussion
In the current study, treatment of human neutrophils with pneumolysin resulted in enhanced expression of CR3 and increased activity of PLA 2 , as well as sensitization of the cells for increased production of superoxide and release of the primary granule enzyme, elastase, on subsequent exposure to FMLP. These proinflammatory actions were observed at concentrations of the toxin (у1.67 ng/mL) that had either no, or minimal, effects on cellular energy metabolism and viability. Although the effects of the toxin on degranulation and PLA 2 activity are similar to those described in some earlier reports [10, 15] , others have reported that exposure of neutrophils to pneumolysin at concentrations equivalent to or lower than those used in the current study results in inhibition of stimulus-activated superoxide production [16, 29, 30] . The reasons for these differences between the earlier studies [16, 29, 30] and the present study are unclear, but they may relate to minor variations in experimental procedures, including the Ca 2ϩ concentration of the cellsuspending medium and the nature of the stimulus used to activate the cells. For example, phorbol esters, which, unlike FMLP, are membrane receptor-and Ca 2ϩ -independent activators of neutrophils [31] , were used in several earlier studies [16, 29, 30] , with inhibition of superoxide production being attributed in one of these to the pore-forming actions of the toxin [16] . It is possible that phorbol esters, which, unlike FMLP, cause prolonged activation of the neutrophil respiratory burst, may potentiate the cytotoxic activity of pneumolysin. We are unaware of other reports on pneumolysin-mediated upregulation of CR3 expression on resting and stimulated neutrophils. This is of potential importance in the recruitment and activation of neutrophils and other types of inflammatory cell during infection with S. pneumoniae.
Transient increases in cytosolic Ca 2ϩ precede and are a prerequisite for activation of many of the proinflammatory activities of neutrophils, including adhesion to vascular endothelium, production of reactive oxidants, degranulation, and activation of cytosolic PLA 2 [32] [33] [34] [35] . In the current study, treatment of neutrophils with proinflammatory concentrations of pneumolysin resulted in a dose-related increase in cytosolic Ca 2ϩ , apparently as a result of an influx of extracellular cation, as opposed to its mobilization from intracellular stores. Evidence for the relationship between pneumolysin-mediated Ca 2ϩ influx and alterations in the proinflammatory activities of neutrophils was strengthened by the observation that the sensitizing effects of the toxin on superoxide production by activated neutrophils were abolished when the cells were suspended in Ca 2ϩ -free medium and by the observation that treatment of neutrophils with a mutant toxin that was attenuated with respect to cytolytic activity did not induce Ca 2ϩ influx or sensitize the cells for increased production of superoxide.
Influx of Ca 2ϩ into pneumolysin-treated neutrophils is probably attributable to the well-documented pore-forming actions of the toxin [1] . Several lines of evidence support this contention. First, the activity of the plasma membrane Ca 2ϩ efflux pump of neutrophils was not inhibited by pneumolysin, ex- cluding interference with discharge of the cation as a possible mechanism of increased cytosolic Ca 2ϩ in these cells. Second, as mentioned above, Ca 2ϩ influx into pneumolysin-treated neutrophils was dependent on the membrane-modifying actions of the toxin, because mutant pneumolysin was ineffective. Additional evidence was derived from experiments in which cells suspended in Ca 2ϩ -free medium were exposed to pneumolysin. This resulted in potentiation of the cytotoxic action of the toxin, which is in agreement with earlier studies in which divalent cations, particularly Ca 2ϩ and Zn 2ϩ , were found to counteract cellular damage inflicted by pneumolysin and other pore-forming toxins [36] [37] [38] . The protective effects of the divalent cations were attributed to voltage-dependent closure of channels rather than to a blocking mechanism [36, 37] . These observations, which may explain the inhibition of superoxide production by pneumolysin-treated, FMLP-activated neutrophils in Ca 2ϩ -free HBSS, suggest that extracellular Ca 2ϩ concentrations at sites of pneumococcal infection may determine the action of pneumolysin-that is, whether it is proinflammatory or cytolytic. In either case, the outcome would be detrimental to the surrounding host tissue.
At the same concentrations that caused influx of Ca 2ϩ and sensitization of the proinflammatory activities of the cells, pneumolysin caused efflux of K ϩ ( 86 Rb ϩ ) and depolarization. These effects of pneumolysin on intracellular K ϩ could not be attributed to direct inhibition of Na ϩ , K ϩ -ATPase, because the activity of this cation transporter was unaffected by the toxin in a cell-free system. Moreover, treatment of neutrophils with vitamin E, which neutralizes lysophospholipids [26] , only partially attenuated the decrease in intracellular K ϩ after exposure of the cells to pneumolysin, suggesting that PLA 2 -mediated inhibition of Na ϩ , K ϩ -ATPase [27] may represent a minor, secondary, indirect mechanism of toxin-induced fluxes of K ϩ . This contention is supported by data from additional experiments, not included in the current study, which showed that treatment of neutrophils with vitamin E partially attenuated pneumolysin-mediated depolarization in these cells (authors' unpublished data). These data are also compatible with a poreforming mechanism of pneumolysin-mediated alterations in fluxes of K ϩ and Na ϩ . In addition to the proinflammatory interactions with human neutrophils described in the current study, pneumolysin has been reported to initiate the production and release of interleukin (IL)-1, IL-6, and tumor necrosis factor-a by human and murine macrophages [11, 39] and to activate inducible NO synthase in these cells [39] . Because induction of NO synthase and cytokine release are dependent on Ca 2ϩ -mediated activation of cytosolic nuclear transcription factors [40] , it is conceivable that influx of Ca 2ϩ may underpin pneumolysin-mediated enhancement of the proinflammatory activities of both neutrophils and macrophages. Taken together, the findings of these and other studies [41] support the involvement of pneumolysin in the pathogenesis of inflammation-mediated tissue damage during pneumococcal infection.
Exaggerated inflammatory responses mediated by pneumolysin may favor microbial survival by promoting premature, auto-oxidative exhaustion of phagocytes [42] and oxidative dysfunction of B and T lymphocytes [43] . Alternatively, release of pneumolysin, which occurs during autolysis of bacteria [1] , may represent a diversionary strategy by which incoming inflammatory cells and proteins are directed toward disintegrating micro-organisms, as opposed to viable bacteria at different sites. In either case, pneumolysin would contribute to microbial persistence.
